Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells.

Srivastava RK, Li C, Khan J, Banerjee NS, Chow LT, Athar M.

Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24583-24592. doi: 10.1073/pnas.1911393116. Epub 2019 Nov 15.

PMID:
31732667
2.

Targeting DNA Damage Response as a Strategy to Treat HPV Infections.

Banerjee NS, Moore D, Parker CJ, Broker TR, Chow LT.

Int J Mol Sci. 2019 Nov 1;20(21). pii: E5455. doi: 10.3390/ijms20215455.

3.

NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.

Banerjee NS, Moore DW, Wang HK, Broker TR, Chow LT.

Antiviral Res. 2019 Oct;170:104559. doi: 10.1016/j.antiviral.2019.104559. Epub 2019 Jul 15. No abstract available.

4.

Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1.

Xu J, Liu H, Yang Y, Wang X, Liu P, Li Y, Meyers C, Banerjee NS, Wang HK, Cam M, Lu W, Chow LT, Xie X, Zhu J, Zheng ZM.

MBio. 2019 Jan 29;10(1). pii: e02687-18. doi: 10.1128/mBio.02687-18.

5.

Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.

Banerjee NS, Moore DW, Broker TR, Chow LT.

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11138-E11147. doi: 10.1073/pnas.1801156115. Epub 2018 Nov 1.

6.

Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures.

Banerjee NS, Wang HK, Beadle JR, Hostetler KY, Chow LT.

Antiviral Res. 2018 Feb;150:164-173. doi: 10.1016/j.antiviral.2017.12.013. Epub 2017 Dec 26. No abstract available.

7.

Conditioned Media From Adipose-Derived Stromal Cells Accelerates Healing in 3-Dimensional Skin Cultures.

Collawn SS, Mobley JA, Banerjee NS, Chow LT.

Ann Plast Surg. 2016 Apr;76(4):446-52. doi: 10.1097/SAP.0000000000000754.

PMID:
26954733
8.

The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem Cells.

Kang L, Yao C, Khodadadi-Jamayran A, Xu W, Zhang R, Banerjee NS, Chang CW, Chow LT, Townes T, Hu K.

Stem Cells Dev. 2016 Apr 1;25(7):556-68. doi: 10.1089/scd.2015.0321.

9.

microRNAs are biomarkers of oncogenic human papillomavirus infections.

Wang X, Wang HK, Li Y, Hafner M, Banerjee NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, Tuschl T, Zheng ZM.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4262-7. doi: 10.1073/pnas.1401430111. Epub 2014 Mar 3.

10.

HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures.

Kho EY, Wang HK, Banerjee NS, Broker TR, Chow LT.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):7542-9. doi: 10.1073/pnas.1304855110. Epub 2013 Apr 9.

11.

Adipose-derived stromal cells accelerate wound healing in an organotypic raft culture model.

Collawn SS, Banerjee NS, de la Torre J, Vasconez L, Chow LT.

Ann Plast Surg. 2012 May;68(5):501-4. doi: 10.1097/SAP.0b013e31823b69fc.

12.

PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro.

Henken FE, Banerjee NS, Snijders PJ, Meijer CJ, De-Castro Arce J, Rösl F, Broker TR, Chow LT, Steenbergen RD.

Mol Cancer. 2011 Jun 10;10:71. doi: 10.1186/1476-4598-10-71.

13.

Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes.

Banerjee NS, Wang HK, Broker TR, Chow LT.

J Biol Chem. 2011 Apr 29;286(17):15473-82. doi: 10.1074/jbc.M110.197574. Epub 2011 Feb 14.

14.

Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.

Jha S, Vande Pol S, Banerjee NS, Dutta AB, Chow LT, Dutta A.

Mol Cell. 2010 Jun 11;38(5):700-11. doi: 10.1016/j.molcel.2010.05.020.

15.

Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6.

Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM.

RNA. 2009 Apr;15(4):637-47. doi: 10.1261/rna.1442309. Epub 2009 Mar 3.

16.

Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.

Genovese NJ, Banerjee NS, Broker TR, Chow LT.

J Virol. 2008 May;82(10):4862-73. doi: 10.1128/JVI.01202-07. Epub 2008 Mar 5.

17.

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.

Stoff-Khalili MA, Rivera AA, Mathis JM, Banerjee NS, Moon AS, Hess A, Rocconi RP, Numnum TM, Everts M, Chow LT, Douglas JT, Siegal GP, Zhu ZB, Bender HG, Dall P, Stoff A, Pereboeva L, Curiel DT.

Breast Cancer Res Treat. 2007 Oct;105(2):157-67. Epub 2007 Jan 13.

PMID:
17221158
18.

Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds.

Stoff A, Rivera AA, Mathis JM, Moore ST, Banerjee NS, Everts M, Espinosa-de-los-Monteros A, Novak Z, Vasconez LO, Broker TR, Richter DF, Feldman D, Siegal GP, Stoff-Khalili MA, Curiel DT.

J Mol Med (Berl). 2007 May;85(5):481-96. Epub 2007 Jan 12.

PMID:
17219096
19.

Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.

Stoff A, Rivera AA, Banerjee NS, Mathis JM, Espinosa-de-los-Monteros A, Le LP, De la Torre JI, Vasconez LO, Broker TR, Richter DF, Stoff-Khalili MA, Curiel DT.

Wound Repair Regen. 2006 Sep-Oct;14(5):608-17.

20.
21.

Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system.

Stoff-Khalili MA, Stoff A, Rivera AA, Banerjee NS, Everts M, Young S, Siegal GP, Richter DF, Wang M, Dall P, Mathis JM, Zhu ZB, Curiel DT.

Breast Cancer Res. 2005;7(6):R1141-52. Epub 2005 Nov 16.

22.
23.

Clonal selection for transcriptionally active viral oncogenes during progression to cancer.

Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, Steenbergen RD, Meijer CL, Snijders PJ, Chatis P, Broker TR, Moen PT Jr, Chow LT.

J Virol. 2004 Oct;78(20):11172-86.

24.

Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system.

Garner-Hamrick PA, Fostel JM, Chien WM, Banerjee NS, Chow LT, Broker TR, Fisher C.

J Virol. 2004 Sep;78(17):9041-50.

25.

Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures.

Banerjee NS, Rivera AA, Wang M, Chow LT, Broker TR, Curiel DT, Nettelbeck DM.

Mol Cancer Ther. 2004 Apr;3(4):437-49.

26.

Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes.

Noya F, Balagué C, Banerjee NS, Curiel DT, Broker TR, Chow LT.

J Virol. 2003 Jun;77(11):6533-40.

27.

The promoter of the human proliferating cell nuclear antigen gene is not sufficient for cell cycle-dependent regulation in organotypic cultures of keratinocytes.

Noya F, Chien WM, Wu X, Banerjee NS, Kappes JC, Broker TR, Chow LT.

J Biol Chem. 2002 May 10;277(19):17271-80. Epub 2002 Feb 27.

Supplemental Content

Loading ...
Support Center